Intracellular uptake, absorption spectrum and stability of the bacteriochlorin photosensitizer 5,10,15,20-tetrakis(m-hydroxyphenyl)bacteriochlorin (mTHPBC). Comparison with 5,10,15,20-tetrakis(m-hydroxyphenyl)chlorin (mTHPC)

Journal of Photochemistry and Photobiology B: Biology

Volumn 37, Issue 3, 1997, Pages 261-266

  Grahn, Michael F ^a   McGuinness, Anita ^a,b   Benzie, Robin ^a   Boyle, Rachael ^b   De Jode, Martin L ^a   Dilkes, Michael G ^c   Abbas, Babar ^b   Williams, Norman S ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

^b KINGSTON UNIVERSITY   (United Kingdom)

^c NORTHWICK PARK HOSPITAL   (United Kingdom)

Author keywords

Cultured cells; Mesoporphyrins; Photochemotherapy; Spectrophotometry

Indexed keywords

BACTERIOCHLORIN; MESOPORPHYRIN; PHOTOSENSITIZING AGENT; SOLVENT;

ANIMAL CELL; ARTICLE; CELL CULTURE; COLON; CONTROLLED STUDY; DRUG POTENCY; DRUG UPTAKE; MOUSE; NONHUMAN; OXIDATION; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; TUMOR CELL; TUMOR CELL LINE;

EID: 0031080063     PISSN: 10111344     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1011-1344(96)07421-0     Document Type: Article

References (17)

1. [1] B.W. Henderson and T.J. Dougherty, How does photodynamic therapy work?, Photochem. Photobiol., 55 (1992) 145-157.
2. [2] D.V. Ash and S.B. Brown, New drugs and future developments in photodynamic therapy, Eur. J. Cancer, 29A (1993) 1781-1783.
3. [3] B.W. Henderson, A.B. Sumlin, B.L. Owczarczak and T.J. Dougherty, Bacteriochlorophyll-a as photosensitizer for photodynamic treatment of transplantable murine tumors, J. Photochem. Photobiol. B: Biol., 10 (1991) 303-313.
4. [4] A.R. Morgan, D. Skalkos, G.M. Garbo, R.W. Keck and S.H. Selman, Synthesis and in vivo photodynamic activity of some bacteriochlorin derivatives against bladder tumors in rodents, J. Med. Chem., 34 (1991) 2126-2133.
5. [5] D. Kessel, K.M. Smith, R.K. Pandey, F.Y. Shiau and B. Henderson, Photosensitization with bacteriochlorins, Photochem. Photobiol., 58 (1993) 200-203.
6. [6] H.L. van Leengoed, J.J. Schuitmaker, N. van der Veen, T.M. Dubbelman and W.M. Star, Fluorescence and photodynamic effects of bacteriochlorin a observed in vivo in "sandwich" observation chambers, Br. J. Cancer, 67 (1993) 898-903.
7. [7] M.C. Berenbaum, S.L. Akande, R. Bonnett, H. Kaur, S. Ioannou, R.D. White and U.-J. Winfield, meso-Tetra(hydroxyphenyl)porphyrins, a new class of potent tumour photosensitisers with favourable selectivity, Br. J. Cancer, 54 (1986) 717-725.
8. [8] R. Bonnett, R.D. White, U.J. Winfield and M.C. Berenbaum, Hydroporphyrins of the meso-tetra(hydroxyphenyl) porphyrin series as tumour photosensitizes, Biochem. J., 261 (1989) 277-280.
9. [9] R. Bonnett, Photosensitizers of the porphyrin and phthalocyanine series for photodynamic therapy, Chem. Soc. Rev., 24 (1995) 19-33.
10. [10] J.C.M. Stewart, Meta-tetra(hydroxyphenyl)-chlorin (m-THPC): a second generation photosensitiser for photodynamic therapy: a review, in D.F. Horrobin (ed.), New Approaches to Cancer Treatment. Unsaturated Lipids and Photodynamic Therapy, Churchill Livingstone, Edinburgh, 1994, pp. 109-120.
11. [11] H.-B. Ris, H.J. Altermatt, B. Nachbur, J.C.M. Stewart, Q. Wang, C.K. Lim, R. Bonnett and U. Althaus, Intraoperative photodynamic therapy with m-tetrahydroxyphenylchlorin for chest malignancies, Lasers Surg. Med., 18 (1996) 39-45.
12. [12] T. Mosmann, Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays, J. Immunol. Methods, 65 (1983) 55-63.
13. [13] J.L. Merlin, S. Azzi, D. Lignon, C. Ramacci, N. Zeghari and F. Guillemin, MTT assays allow quick and reliable measurement of the response of human tumour cells to photodynamic therapy, Eur. J. Cancer, 28A (1992) 1452-1458.
14. [14] L. Ma, J. Moan and K. Berg, Evaluation of a new photosensitizer, meso-tetrahydroxyphenyl-chlorin, for use in photodynamic therapy: a comparison of its photobiological properties with those of two other photosensitizers, Int. J. Cancer, 57 (1994) 883-888.
15. [15] M.L. de Jode, M.G. Dilkes, M.F. Grahn, P.B. Hart and A. Raven, New LED light source for photodynamic therapy: preclinical study, in S. Andersson-Engels, M. Corti, I. Kertész, T.A. King, N. Kroó, R. Patesi, S. Seeger and H.P. Weber (eds.), Proc. SPIE 2629, Biomedical Optoelectronics in Clinical Chemistry and Biotechnology, SPIE, Bellingham, WA, 1996, pp. 299-305.
16. [16] R. Bays, G. Wagnieres, D. Braichotte, H. van den Bergh, P. Monnier and J.-F. Savary, Tissue optics and dosimetry for photodynamic cancer therapy in the oesophagus, in G. Jori, J. Moan, W.M. Star and A. Katzir (eds.), Proc. SPIE 2078, Proceedings of Photodynamic Therapy of Cancer, SPIE, Bellingham, WA, 1993, pp. 13-26.
17. [17] H. Van den Bergh, Photodynamic therapy and photodetection of early cancer in the upper aerodigestive tract, the tracheobronchial tree, the esophagus and the urinary-bladder, in U. Amaldi and B. Larsson (eds.), International Congress Series 1077, Hadrontherapy in Oncology, Elsevier, New York, 1994, pp. 577-621.